Ligand Pharmaceuticals
LGND
LGND
174 hedge funds and large institutions have $1.04B invested in Ligand Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 73 increasing their positions, 58 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
40% less call options, than puts
Call options by funds: $5.04M | Put options by funds: $8.41M
49% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 37
Holders
174
Holding in Top 10
5
Calls
$5.04M
Puts
$8.41M
Top Buyers
| 1 | +$23.3M | |
| 2 | +$19.9M | |
| 3 | +$17.3M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$12M |
Top Sellers
| 1 | -$36.9M | |
| 2 | -$16.2M | |
| 3 | -$14.3M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$9.51M |
| 5 |
TA
Teachers Advisors
New York
|
-$7.73M |